CCR Ostrava s.r.o.

At CCR Ostrava s.r.o., research in cardiovascular diseases focuses on conditions such as atherosclerotic cardiovascular disease, hypertension, and heart failure. These studies are designed to test new ways to lower the risk of serious heart and stroke events, improve heart failure outcomes, and better manage patients with elevated cardiovascular risk.

• Prevention of heart attack, stroke, and cardiovascular death in people at high risk
• Studies in heart failure, including patients with obesity or kidney impairment
• Evaluation of therapies aimed at improving blood pressure control and vascular protection

Overall, this therapeutic area is centered on finding more effective treatments for long-term cardiovascular risk reduction and better disease control.

The site has a strong program in skin and connective tissue diseases and immune system diseases, with studies in atopic dermatitis, plaque psoriasis, alopecia areata, and hidradenitis suppurativa. These trials mainly aim to assess how well new treatments reduce symptoms, improve skin healing, and support longer-term disease control.

• Testing therapies for moderate to severe atopic dermatitis and itch relief
• Research in psoriasis and psoriatic arthritis to reduce inflammation and skin/joint symptoms
• Studies in alopecia areata and hidradenitis suppurativa to improve visible disease outcomes and quality of life

This is one of the most active research areas at CCR Ostrava, reflecting broad interest in chronic inflammatory skin disorders.

Clinical trials in musculoskeletal diseases at this site include psoriatic arthritis, rheumatoid arthritis, axial spondyloarthritis, and chronic pain conditions such as knee osteoarthritis and low back pain. The research is aimed at improving symptom relief, reducing inflammation, and helping patients maintain mobility and daily function.

• New treatment options for active psoriatic arthritis and related inflammatory joint disease
• Studies on chronic pain from osteoarthritis and non-specific low back pain
• Evaluation of therapies for broader rheumatologic disease control

These studies support better management of both inflammatory and degenerative joint and pain disorders.

Research in digestive system diseases includes trials for ulcerative colitis and other inflammatory bowel conditions. The main purpose is to evaluate treatments that can reduce intestinal inflammation, achieve remission, and maintain disease control over time.

• Induction and maintenance studies in moderately to severely active ulcerative colitis
• Comparisons of newer therapies with established treatment options
• Assessment of disease remission and longer-term symptom control

This field reflects a clear focus on improving outcomes for people living with chronic inflammatory bowel disease.

The site also conducts studies in nervous system diseases, especially migraine. These trials are designed to evaluate both acute and preventive approaches, with the goal of lowering attack frequency, easing pain, and improving day-to-day functioning for people affected by recurrent headaches.

• Acute treatment studies for single migraine attacks
• Prevention-focused research for chronic and episodic migraine
• Long-term evaluation of safety and tolerability for migraine therapies

These projects contribute to better options for patients with persistent headache disorders.

Trials in nutritional and metabolic diseases at CCR Ostrava s.r.o. address obesity, hypertriglyceridemia, and related metabolic risk states. The research is focused on supporting weight reduction, improving lipid levels, and lowering the chance of complications linked to metabolic disease.

• Studies of treatments for chronic weight management
• Research in high triglycerides and severe hypertriglyceridemia
• Evaluation of therapies that may improve metabolic and cardiovascular health together

These trials reflect a growing emphasis on the connection between metabolism, body weight, and long-term health.

Within respiratory tract diseases, the site is involved in studies of chronic obstructive pulmonary disease. The purpose of this research is to assess whether new treatment approaches can improve breathing-related outcomes and reduce the broader impact of lung disease on patients’ health.

• Evaluation of therapies aimed at improving respiratory symptoms and cardiopulmonary outcomes
• Research on better disease control in chronic lung disease
• Studies that consider both lung function and overall patient well-being

This area adds an important pulmonary medicine dimension to the site’s clinical trial portfolio.

The trial portfolio at CCR Ostrava also includes studies that cross several therapeutic areas, especially conditions driven by chronic inflammation. These trials examine whether new therapies can improve disease activity across different body systems and offer more durable control for complex disorders.

• Inflammatory diseases affecting the skin, joints, and digestive tract
• Trials designed to compare new treatments with placebo or established options
• Research aimed at improving long-term safety, symptom relief, and treatment response

This mixed portfolio highlights the site’s role in advancing immune-mediated disease research across multiple specialties.